By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Sarajevo TimesSarajevo TimesSarajevo Times
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Search
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Reading: Australia Approves First Drug For Treatment Of Alzheimer’s Disease
Share
Font ResizerAa
Sarajevo TimesSarajevo Times
Font ResizerAa
  • HOME
  • POLITICS
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
  • SPORT
  • ARTS
  • W&N
Search
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Follow US
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2012 Sarajevo Times. All rights reserved.
Sarajevo Times > Blog > WORLD NEWS > Australia Approves First Drug For Treatment Of Alzheimer’s Disease
WORLD NEWS

Australia Approves First Drug For Treatment Of Alzheimer’s Disease

Published: September 8, 2025
Share
SHARE

The Australian Agency for the Regulation of Drugs and Therapies has approved the first drug for the treatment of Alzheimer’s disease.

The Therapeutic Goods Administration (TGA) approved the drug Donanemab, which has been found to slow the progression of Alzheimer’s disease by clearing protein from the brain.

The drug is intended for people with mild cognitive impairment or mild dementia caused by Alzheimer’s disease, which is the most common type of dementia. It is the leading cause of death among women in Australia and the second most common among men.

The drug is administered as an intravenous infusion every four weeks, for a maximum of 18 months.

Clinical trials have shown that it can help in the early stages of Alzheimer’s disease.

However, it cannot cure or stop cognitive decline. But it can slow the disease and allow people a better quality of life for a longer time.

The drug, which is already approved in the United Kingdom (UK) and the United States (U.S.), is not listed at this stage in the Pharmaceutical Benefits Scheme, which means it is not subsidized by the government and its use will cost between 40.000 and 80.000 dollars per year.

However, health experts warn of side effects such as brain swelling and bleeding, calling for careful monitoring.

How Bosniaks Saved Nearly 15.000 Croats In 1991: A Fact Forgotten In Zagreb
The Israelis were planning a much bigger and stronger Attack on Iran?
The Netherlands Compensation Commission Potocari is no longer processing Requests
Rouhani wins Iran’s presidential election with 57 pct of ballots
Weather forecast for world cities
Share This Article
Facebook Whatsapp Whatsapp Telegram Threads Bluesky Email Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Poland and Allies Scramble Jets Following Russian Strikes on Ukraine
Next Article Two More Military Industry Factories Set to Open in FBiH
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Stay Connected

10.2KFollowersLike
10.1KFollowersFollow
414FollowersFollow

Latest News

Constitutional Court of BiH: Republika Srpska Can’t Ban the Insignia of the Army of RBiH
November 22, 2026
Dragons Played Against Denmark Six Times: Two Wins and Two Draws Ahead of the Big Playoff
November 22, 2026
EUFOR Joins Diplomatic Winter Bazaar in Sarajevo
November 22, 2026
2nd International Judo Tournament ‘BH Open’ gathers more than 500 Competitors
November 22, 2026
Anniversary of Death of Mustafa Nadarevic, Bosnian famous Actor
November 22, 2026
Students from BiH who study and work in Croatia could obtain an additional Pension Period
November 22, 2026
BiH’s Economy is growing, but the European Commission warns of Concerning Indicators
November 22, 2026
Minic continues Consultations on the Selection of the Prime-Designate to form the new RS Government
November 22, 2026
Diplomatic Winter Bazaar, a Place to Meet and Help
November 21, 2026
SIPA in the City Administration of Bijeljina over the War Criminal Ratko Mladic’ Mural
November 21, 2026
Sarajevo TimesSarajevo Times
Follow US
© 2012 Sarajevo Times. All Rights Reserved.
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?